Health Effects of Wood Smoke and Traffic-Related Air Pollution Exposures: a Necessary Comparison
Launched by UNIVERSITY OF BRITISH COLUMBIA · Dec 17, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on understanding how different types of air pollution affect our health. Specifically, researchers want to compare the health impacts of wood smoke—like that from wildfires and using wood for heating—and traffic-related air pollution. These types of pollution are common in Canada and can lead to serious health problems over time. The study aims to safely expose healthy volunteers to these pollutants in a controlled setting to see how they affect the body.
To be eligible for this study, participants need to be between 19 and 40 years old, healthy, and have never smoked or vaped. Unfortunately, if someone is pregnant, planning to become pregnant, or breastfeeding, they won't be able to participate. During the study, participants will undergo tests and evaluations to monitor their health after exposure to the different air pollutants. It's important to note that the trial is not yet recruiting participants, so there may be a wait before it starts. This research could help us better understand the health risks associated with air pollution and ultimately improve public health.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age 19-40
- • Healthy, with no history of respiratory disease
- • Lifetime non-smoker and non-vaper.
- Exclusion Criteria:
- • Pregnant, planning to become pregnant, or breastfeeding during the study period (confirmed through pregnancy tests at each visit if applicable)
- • Frequent WS or DE exposures (e.g. home fireplace used for heating/cooking, or employment in transportation, mining, or as a firefighter).
About University Of British Columbia
The University of British Columbia (UBC) is a leading research institution located in Vancouver, Canada, renowned for its commitment to advancing health sciences through innovative research and education. As a prominent clinical trial sponsor, UBC leverages its interdisciplinary expertise and state-of-the-art facilities to conduct rigorous clinical studies aimed at improving patient outcomes across various medical fields. The university fosters collaborations with healthcare professionals, industry partners, and community stakeholders to translate research findings into practical applications, thereby contributing to the global advancement of medicine and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Vancouver, British Columbia, Canada
Patients applied
Trial Officials
Chris Carlsten, MD
Principal Investigator
University of British Columbia
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported